|
1
|
Determinants of antileukemia effects of allogeneic NK cells.
|
J Immunol
|
2004
|
2.85
|
|
2
|
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95.
|
Blood
|
2008
|
2.68
|
|
3
|
Consolidation treatment with chimeric anti-GD2-antibody ch14.18 in children older than 1 year with metastatic neuroblastoma.
|
J Clin Oncol
|
2004
|
1.64
|
|
4
|
Outcome of allogeneic stem cell transplantation in children with non-malignant diseases.
|
Haematologica
|
2006
|
1.47
|
|
5
|
Biology and plasticity of CD133+ hematopoietic stem cells.
|
Ann N Y Acad Sci
|
2003
|
1.45
|
|
6
|
Evolution in health and medicine Sackler colloquium: Making evolutionary biology a basic science for medicine.
|
Proc Natl Acad Sci U S A
|
2009
|
1.45
|
|
7
|
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy?
|
J Clin Oncol
|
2004
|
1.39
|
|
8
|
Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR.
|
Br J Haematol
|
2005
|
1.35
|
|
9
|
Long-term outcome after haploidentical stem cell transplantation in children.
|
Blood Cells Mol Dis
|
2004
|
1.30
|
|
10
|
Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95.
|
J Clin Oncol
|
2006
|
1.09
|
|
11
|
Alpha-CD25 antibody treatment in a child with hemophagocytic lymphohistiocytosis.
|
Med Pediatr Oncol
|
2002
|
1.05
|
|
12
|
Graft-versus-Ewing sarcoma effect and long-term remission induced by haploidentical stem-cell transplantation in a patient with relapse of metastatic disease.
|
J Clin Oncol
|
2005
|
1.04
|
|
13
|
Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
|
Exp Hematol
|
2004
|
1.01
|
|
14
|
Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors.
|
Br J Haematol
|
2004
|
1.00
|
|
15
|
Detection of adenovirus-specific T cells in children with adenovirus infection after allogeneic stem cell transplantation.
|
Br J Haematol
|
2005
|
1.00
|
|
16
|
Haematopoietic stem cell transplantation for Shwachman-Diamond disease: a study from the European Group for blood and marrow transplantation.
|
Br J Haematol
|
2005
|
0.99
|
|
17
|
Identification of a novel class of human adherent CD34- stem cells that give rise to SCID-repopulating cells.
|
Blood
|
2002
|
0.98
|
|
18
|
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts.
|
Blood
|
2004
|
0.96
|
|
19
|
Stem cell transplantation for chronic myeloid leukemia in children.
|
Blood
|
2003
|
0.94
|
|
20
|
Chimaerism analyses and subsequent immunological intervention after stem cell transplantation in patients with juvenile myelomonocytic leukaemia.
|
Br J Haematol
|
2005
|
0.93
|
|
21
|
Sequential expression of adhesion and costimulatory molecules in graft-versus-host disease target organs after murine bone marrow transplantation across minor histocompatibility antigen barriers.
|
Biol Blood Marrow Transplant
|
2005
|
0.93
|
|
22
|
Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy.
|
Eur J Pediatr
|
2002
|
0.93
|
|
23
|
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).
|
Br J Haematol
|
2005
|
0.93
|
|
24
|
Adult stem cells as an alternative source of multipotential (pluripotential) cells in regenerative medicine.
|
Curr Stem Cell Res Ther
|
2009
|
0.90
|
|
25
|
Onset of thymic recovery and plateau of thymic output are differentially regulated after stem cell transplantation in children.
|
Biol Blood Marrow Transplant
|
2005
|
0.90
|
|
26
|
Transplantation of highly purified CD34+ progenitor cells from unrelated donors in pediatric leukemia.
|
Blood
|
2002
|
0.89
|
|
27
|
Cytotoxic activity of natural killer cells lacking killer-inhibitory receptors for self-HLA class I molecules against autologous hematopoietic stem cells in healthy individuals.
|
Exp Mol Pathol
|
2004
|
0.88
|
|
28
|
Haploidentical transplantation for acute lymphoblastic leukemia in childhood.
|
Blood Rev
|
2004
|
0.87
|
|
29
|
Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell-receptor repertoire complexity following transplantation of T-cell-depleted CD34-selected hematopoietic progenitor cells from unrelated donors.
|
Blood
|
2002
|
0.86
|
|
30
|
Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation.
|
Br J Haematol
|
2003
|
0.85
|
|
31
|
Megadose transplantation of highly purified haploidentical stem cells: current results and future prospects.
|
Pediatr Transplant
|
2003
|
0.84
|
|
32
|
Sequence polymorphism systems for quantitative real-time polymerase chain reaction to characterize hematopoietic chimerism-high informativity and sensitivity as well as excellent reproducibility and precision of measurement.
|
Lab Hematol
|
2007
|
0.83
|
|
33
|
Down-regulation of protein kinase Ceta by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel.
|
Cancer Lett
|
2004
|
0.83
|
|
34
|
Stem cell transplantation for polycythemia vera.
|
Pediatr Blood Cancer
|
2008
|
0.83
|
|
35
|
Cytotoxic minor histocompatibility antigen HA-1-specific CD8+ effector memory T cells: artificial APCs pave the way for clinical application by potent primary in vitro induction.
|
Blood
|
2005
|
0.80
|
|
36
|
Bone marrow-derived factors support growth of N-type, but not of melanocytic neuroblastoma cells.
|
Anticancer Res
|
2003
|
0.79
|
|
37
|
Receptor activator of nuclear factor kappaB ligand plays a nonredundant role in doxorubicin-induced apoptosis.
|
Cancer Res
|
2003
|
0.78
|
|
38
|
Pitfalls in detection of contaminating neuroblastoma cells by tyrosine hydroxylase RT-PCR due to catecholamine-producing hematopoietic cells.
|
Anticancer Res
|
2006
|
0.78
|
|
39
|
Induction of drug resistance and protein kinase C genes in A2780 ovarian cancer cells after incubation with antineoplastic agents at sublethal concentrations.
|
Anticancer Res
|
2003
|
0.77
|
|
40
|
Gene therapy for severe combined immunodeficiency disease.
|
N Engl J Med
|
2002
|
0.77
|
|
41
|
Expression and regulation of B7 family molecules on macrophages (MPhi) in preterm and term neonatal cord blood and peripheral blood of adults.
|
Cytometry B Clin Cytom
|
2003
|
0.77
|
|
42
|
Children with myelodysplastic syndrome (MDS) and increasing mixed chimaerism after allogeneic stem cell transplantation have a poor outcome which can be improved by pre-emptive immunotherapy.
|
Br J Haematol
|
2005
|
0.77
|
|
43
|
CD34 stem cell dose and development of extensive chronic graft-versus-host disease.
|
Blood
|
2002
|
0.75
|
|
44
|
Experiences with haploidentical stem cell transplantation in children with acute lymphoblastic leukemia.
|
Pathol Biol (Paris)
|
2005
|
0.75
|
|
45
|
Organ-specific T cell receptor repertoire in target organs of murine graft-versus-host after transplantation across minor histocompatibility antigen barriers.
|
Transplantation
|
2004
|
0.75
|
|
46
|
Low-density lipoprotein modification by normal, myeloperoxidase-deficient and NADPH oxidase-deficient granulocytes and the impact of redox active transition metal ions.
|
Redox Rep
|
2002
|
0.75
|
|
47
|
Potential pitfalls of comparative measurements of reticulocytes with flow cytometry and microscopy in prematures and infants.
|
Clin Chem Lab Med
|
2004
|
0.75
|
|
48
|
Differences in the accumulation of ascorbic acid in normal, myeloperoxidase deficient and NADPH-oxidase deficient granulocytes.
|
Int J Vitam Nutr Res
|
2002
|
0.75
|
|
49
|
[Until recently the dominant philosophy was to keep the truth from terminally ill children. This is fundamentally wrong. A plea. Speaking is gold].
|
Pflege Z
|
2014
|
0.75
|
|
50
|
Impaired T-cell activation and cytokine productivity after transplantation of positively selected CD34+ allogeneic hematopoietic stem cells.
|
Hematol J
|
2004
|
0.75
|